Prognosis research strategy (PROGRESS) 4: stratified medicine research

Aroon D Hingorani; Daniëlle A van der Windt; Richard D Riley; Keith Abrams; Karel G M Moons; Ewout W Steyerberg; Sara Schroter; Willi Sauerbrei; Douglas G Altman; Harry Hemingway; PROGRESS Group

Prognosis research strategy (PROGRESS) 4: stratified medicine research

Aroon D Hingorani, Daniëlle A van der Windt, Richard D Riley, Keith Abrams, Karel G M Moons, Ewout W Steyerberg, Sara Schroter, Willi Sauerbrei, Douglas G Altman, Harry Hemingway, PROGRESS Group

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	e5793
Journal	British Medical Journal
Volume	346
Publication status	Published - 2013

Keywords

Randomized Controlled Trials as Topic
Humans
Prognosis
Technology Assessment, Biomedical
Health Policy
Risk Assessment
False Positive Reactions
False Negative Reactions
Individualized Medicine
Biomedical Research
Cost-Benefit Analysis
Diagnostic Techniques and Procedures
Delivery of Health Care
Decision Support Techniques
Research Support as Topic

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{848b837b9027495b8fa365355ed630f1,

title = "Prognosis research strategy (PROGRESS) 4: stratified medicine research",

keywords = "Randomized Controlled Trials as Topic, Humans, Prognosis, Technology Assessment, Biomedical, Health Policy, Risk Assessment, False Positive Reactions, False Negative Reactions, Individualized Medicine, Biomedical Research, Cost-Benefit Analysis, Diagnostic Techniques and Procedures, Delivery of Health Care, Decision Support Techniques, Research Support as Topic",

author = "Hingorani, {Aroon D} and Windt, {Dani{\"e}lle A van der} and Riley, {Richard D} and Keith Abrams and Moons, {Karel G M} and Steyerberg, {Ewout W} and Sara Schroter and Willi Sauerbrei and Altman, {Douglas G} and Harry Hemingway and {PROGRESS Group}",

year = "2013",

language = "English",

volume = "346",

pages = "e5793",

journal = "British Medical Journal",

issn = "1756-1833",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Prognosis research strategy (PROGRESS) 4

T2 - stratified medicine research

AU - Hingorani, Aroon D

AU - Windt, Daniëlle A van der

AU - Riley, Richard D

AU - Abrams, Keith

AU - Moons, Karel G M

AU - Steyerberg, Ewout W

AU - Schroter, Sara

AU - Sauerbrei, Willi

AU - Altman, Douglas G

AU - Hemingway, Harry

AU - PROGRESS Group

PY - 2013

Y1 - 2013

KW - Randomized Controlled Trials as Topic

KW - Humans

KW - Prognosis

KW - Technology Assessment, Biomedical

KW - Health Policy

KW - Risk Assessment

KW - False Positive Reactions

KW - False Negative Reactions

KW - Individualized Medicine

KW - Biomedical Research

KW - Cost-Benefit Analysis

KW - Diagnostic Techniques and Procedures

KW - Delivery of Health Care

KW - Decision Support Techniques

KW - Research Support as Topic

M3 - Article

C2 - 23386361

SN - 1756-1833

SN - 1468-5833

VL - 346

SP - e5793

JO - British Medical Journal

JF - British Medical Journal

ER -